Risk-Adapted Starting Age of Personalized Lung Cancer Screening A Population-Based, Prospective Cohort Study in China

被引:1
作者
Wang, Chenran [1 ]
Dong, Xuesi [1 ]
Tan, Fengwei [2 ]
Wu, Zheng [3 ]
Huang, Yufei [2 ]
Zheng, Yadi [1 ]
Luo, Zilin [1 ]
Xu, Yongjie [1 ]
Zhao, Liang [1 ]
Li, Jibin [1 ]
Zou, Kaiyong [1 ]
Cao, Wei [1 ]
Wang, Fei [1 ]
Ren, Jiansong [1 ]
Shi, Jufang [1 ]
Chen, Wanqing [1 ]
He, Jie [2 ]
Li, Ni [1 ,4 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Off Canc Screening, Beijing, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Dept Thorac Surg, Natl Canc Ctr,Natl Clin Res Ctr Canc, Beijing, Peoples R China
[3] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China
[4] Nanjing Med Univ, Collaborat Innovat Ctr Canc Personalized Med, Dept Epidemiol & Biostat, Jiangsu Key Lab Canc Biomarkers Prevent & Treatmen, Nanjing, Peoples R China
关键词
lung cancer; personalized screening; risk-adapted screening; risk factors; starting age of screening; NEVER-SMOKERS; FAMILY-HISTORY; ASSOCIATION; MORTALITY; DISEASES; SMOKING;
D O I
10.1016/j.chest.2024.01.031
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
BACKGROUND: The current one-size-fits fi ts-all screening strategy for lung cancer is not suitable for personalized screening. RESEARCH QUESTION: What is the risk-adapted starting age of lung cancer screening with comprehensive consideration of risk factors? STUDY DESIGN AND METHODS: The National Lung Cancer Screening program, a multicenter, population-based, prospective cohort study, was analyzed. Information on risk factor exposure was collected during the baseline risk assessment. A Cox proportional hazards model was used to estimate the association between risk factors and lung cancer incidence. Age-specific fi c 10-year cumulative risk was calculated to determine the age at which individuals with various risk factors reached the equivalent risk level as individuals aged >= 50 years with active tobacco use and a >= 20 pack-year smoking history. RESULTS: Of the 1,031,911 participants enrolled in this study, 3,908 demonstrated lung cancer after a median follow-up of 3.8 years. We identified fi ed seven risk factors for lung cancer, including pack-years of smoking, secondhand smoke exposure, family history of lung cancer in fi rst-degree relatives, history of respiratory diseases, occupational hazardous exposure, BMI, and diabetes. The 10-year cumulative risk of lung cancer for people aged >= 50 years with active tobacco use and a >= 20 pack-year smoking history was 1.37%, which was treated as the risk threshold for screening. Individuals who never smoked and those with active tobacco use and a < 30-pack-year history of smoking reached the equivalent risk level 1 to 14 years later compared with the starting age of 50 years. Men with active tobacco use, a >= 30- pack-year history of smoking, and concurrent respiratory diseases or diabetes should be screened 1 year earlier at the age of 49 years. INTERPRETATION: The personalized risk-adapted starting ages for lung cancer screening, based on the principle of equal management of equal risk, can served as an optimized screening strategy to identify high-risk individuals.
引用
收藏
页码:1538 / 1554
页数:17
相关论文
共 49 条
  • [1] Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
    Aberle, Denise R.
    Adams, Amanda M.
    Berg, Christine D.
    Black, William C.
    Clapp, Jonathan D.
    Fagerstrom, Richard M.
    Gareen, Ilana F.
    Gatsonis, Constantine
    Marcus, Pamela M.
    Sicks, JoRean D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (05) : 395 - 409
  • [2] 13. Diabetes Care in the Hospital
    不详
    [J]. DIABETES CARE, 2016, 39 : S99 - S104
  • [3] Association between previous lung diseases and lung cancer risk: a systematic review and meta-analysis
    Ang, Lina
    Ghosh, Pratyusha
    Seow, Wei Jie
    [J]. CARCINOGENESIS, 2021, 42 (12) : 1461 - 1474
  • [4] Association between family history of lung cancer and lung cancer risk: a systematic review and meta-analysis
    Ang, Lina
    Chan, Cheryl Pui Yi
    Yau, Wai-Ping
    Seow, Wei Jie
    [J]. LUNG CANCER, 2020, 148 : 129 - 137
  • [5] [Anonymous], 1998, Guidelines for controlling and monitoring the tobacco epidemic, P76
  • [6] Lung cancer in never-smokers: a hidden disease
    Bhopal, Anand
    Peake, Michael D.
    Gilligan, David
    Cosford, Paul
    [J]. JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 2019, 112 (07) : 269 - 271
  • [7] Uptake of lung cancer screening with low-dose computed tomography in China: A multi-centre population-based study
    Cao, Wei
    Tan, Fengwei
    Liu, Kuangyu
    Wu, Zheng
    Wang, Fei
    Yu, Yiwen
    Wen, Yan
    Qin, Chao
    Xu, Yongjie
    Zhao, Liang
    Tang, Wei
    Li, Jiang
    Dong, Xuesi
    Zheng, Yadi
    Yang, Zhuoyu
    Su, Kai
    Li, Fang
    Shi, Jufang
    Ren, Jiansong
    Liu, Yunyong
    Yu, Lianzheng
    Wei, Donghua
    Dong, Dong
    Cao, Ji
    Zhang, Shaokai
    Yan, Shipeng
    Wang, Ning
    Du, Lingbin
    Chen, Wanqing
    Li, Ni
    He, Jie
    [J]. ECLINICALMEDICINE, 2022, 52
  • [8] Chan KH, 2022, LANCET PUBLIC HEALTH, V7, pE1014, DOI 10.1016/S2468-2667(22)00227-4
  • [9] Ambient Air Pollution and Lung Cancer: Nature and Nurture
    Christiani, David C.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 204 (07) : 752 - 753
  • [10] Survival among Never-Smokers with Lung Cancer in the Cancer Care Outcomes Research and Surveillance Study
    Clement-Duchene, Christelle
    Stock, Shannon
    Xu, Xiangyan
    Chang, Ellen T.
    Gomez, Scarlett Lin
    West, Dee W.
    Wakelee, Heather A.
    Gould, Michael K.
    [J]. ANNALS OF THE AMERICAN THORACIC SOCIETY, 2016, 13 (01) : 58 - 66